Pharmaceutical Lawsuit and Recall Information
At RxRecall.com, our pharmaceutical litigation and defective drug lawyers are committed to serving personal injury victims and are well versed in the product liability laws that protect consumers.
Pradaxa is a blood thinner with NO antidote In contrast Warfarin (a blood thinner) that has an antidote to reverse the blood-thinning effects, Pradaxa does not, making some doctors feel helpless when a patient on Pradaxa starts bleeding. “You feel helpless, and that’s a very bad feeling for us” said Dr. Cotton from the Memorial [...]
Pradaxa – Most Dangerous Drug In 2011 The Food and Drug Administration received 179,855 reports of fatal or serious drug reactions. The FDA received these reports from consumers and healthcare professionals that were reporting deadly and serious side effects of medication. (philly.com) In the list of the top ten most reported medications, Pradaxa was the [...]
Pradaxa Side Effects – FDA Update In December of 2011 the FDA conducted an investigation of reports of patients using Pradaxa in order to see if the rate of serious side effects is greater than first projected by the manufacturer. Pradaxa, a blood thinner, became available in the U.S. in October 2010. It is used [...]
Pradaxa (Dabigatran) What Is Pradaxa? Pradaxa is a medicine to keep your blood from coagulating (clotting) in order to prevent dangerous blood clots. Pradaxa also increases the chances of bleeding to occur, even from minor injury. Avoid activities that may increase your risk of bleeding or injury while taking Pradaxa. Pradaxa Side Effects Pradaxa users [...]
PRADAXA One month after 50 cases of fatal bleeding incidents were reported, the U.S. Food and Drug Administration announced that it will conduct a complete safety review of the drug, Pradaxa (dabigatran). Pradaxa is an oral direct thrombin inhibitor that is used to prevent stroke in patients suffering from non valvular atrial fibrillation. The FDA’s [...]
Pradaxa Side Effects The FDA is evaluating reports of serious bleeding in Pradaxa patients. Pradaxa is a blood thinner used tho help prevent stroke in heart patients. Bleeding may lead to serious consequences while on Pradaxa. The label contains a warning about “significant and sometimes fatal bleeds”. As of now, FDA advices patients to continue [...]
The U.S. Food and Drug Administration announced this week that it will conduct a complete safety review of the drug, Pradaxa (dabigatran), following reports that it may cause excessive bleeding. Pradaxa is an oral direct thrombin inhibitor that is used to prevent stroke in patients suffering from nonvalvular atrial fibrillation. The FDA’s safety review announcement [...]
